Empagliflozin and hydralazine-isosorbide dinitrate combination therapy improves outcomes in black patients with heart failure
{{output}}
Background: Black patients experience a disproportionately high incidence of heart failure with reduced ejection fraction (HFrEF), where vasodilators serve as a key therapeutic strategy. ... ...
